Page last updated: 2024-08-25

magnolol and Colorectal Neoplasms

magnolol has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, JH; Hsu, FT; Kuan, LY; Su, CM; Weng, YS1
Chung, HJ; Kang, YJ; Lee, MA; Lee, SK; Min, HY; Park, EJ; Park, HJ; Shin, Y1

Other Studies

2 other study(ies) available for magnolol and Colorectal Neoplasms

ArticleYear
Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
    International journal of molecular sciences, 2020, May-16, Volume: 21, Issue:10

    Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Disease Progression; Humans; Lignans; Male; Mice, Inbred BALB C; Mitochondria; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Protein Kinase C-delta; Protein Kinase Inhibitors; Receptors, Death Domain; Signal Transduction

2020
Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Molecular pharmacology, 2012, Volume: 82, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; beta Catenin; Biphenyl Compounds; Colorectal Neoplasms; Female; HCT116 Cells; HEK293 Cells; Humans; Lignans; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Wnt3A Protein; Xenograft Model Antitumor Assays

2012